BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 29876310)

  • 1. Advanced proton beam dosimetry part II: Monte Carlo
    Maes D; Saini J; Zeng J; Rengan R; Wong T; Bowen SR
    Transl Lung Cancer Res; 2018 Apr; 7(2):114-121. PubMed ID: 29876310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiobiological and dosimetric impact of RayStation pencil beam and Monte Carlo algorithms on intensity-modulated proton therapy breast cancer plans.
    Rana S; Greco K; Samuel EJJ; Bennouna J
    J Appl Clin Med Phys; 2019 Aug; 20(8):36-46. PubMed ID: 31343826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Monte Carlo versus Pencil Beam Treatment Planning in Nasopharyngeal Patients Receiving IMPT.
    Sasidharan BK; Aljabab S; Saini J; Wong T; Laramore G; Liao J; Parvathaneni U; Bowen SR
    Int J Part Ther; 2019; 5(4):32-40. PubMed ID: 31773039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative assessment of the accuracy of dose calculation using pencil beam and Monte Carlo algorithms and requirements for clinical quality assurance.
    Ali I; Ahmad S
    Med Dosim; 2013; 38(3):255-61. PubMed ID: 23558145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comprehensive dosimetric study of Monte Carlo and pencil-beam algorithms on intensity-modulated proton therapy for breast cancer.
    Liang X; Li Z; Zheng D; Bradley JA; Rutenberg M; Mendenhall N
    J Appl Clin Med Phys; 2019 Jan; 20(1):128-136. PubMed ID: 30488548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of the normalized prescription isodose line on the magnitude of Monte Carlo vs. pencil beam target dose differences for lung stereotactic body radiotherapy.
    Zheng D; Zhang Q; Liang X; Zhu X; Verma V; Wang S; Zhou S
    J Appl Clin Med Phys; 2016 Jul; 17(4):48-58. PubMed ID: 27455476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of proton dose calculation algorithms on the interplay effect in PBS proton based SBRT lung plans.
    Rana S; Rosenfeld AB
    Biomed Phys Eng Express; 2021 May; 7(4):. PubMed ID: 34029212
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparative photon and proton dosimetry for patients with mediastinal lymphoma in the era of Monte Carlo treatment planning and variable relative biological effectiveness.
    Tseng YD; Maes SM; Kicska G; Sponsellor P; Traneus E; Wong T; Stewart RD; Saini J
    Radiat Oncol; 2019 Dec; 14(1):243. PubMed ID: 31888769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of Monte Carlo algorithm for compliance with RTOG 0915 dosimetric criteria in peripheral lung cancer patients treated with stereotactic body radiotherapy.
    Pokhrel D; Sood S; Badkul R; Jiang H; McClinton C; Lominska C; Kumar P; Wang F
    J Appl Clin Med Phys; 2016 May; 17(3):277-293. PubMed ID: 27167284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dosimetric comparison of iPlan
    Menon SV; Paramu R; Bhasi S; Gopalakrishnan Z; Bhaskaran S; Nair RK
    Med Dosim; 2020 Autumn; 45(3):225-234. PubMed ID: 32001069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small spot size versus large spot size: Effect on plan quality for lung cancer in pencil beam scanning proton therapy.
    Rana S; Rosenfeld AB
    J Appl Clin Med Phys; 2022 Feb; 23(2):e13512. PubMed ID: 34989458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation and application of a fast Monte Carlo algorithm for assessing the clinical impact of approximations in analytical dose calculations for pencil beam scanning proton therapy.
    Huang S; Souris K; Li S; Kang M; Barragan Montero AM; Janssens G; Lin A; Garver E; Ainsley C; Taylor P; Xiao Y; Lin L
    Med Phys; 2018 Dec; 45(12):5631-5642. PubMed ID: 30295950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advanced Proton Beam Dosimetry Part I: review and performance evaluation of dose calculation algorithms.
    Saini J; Traneus E; Maes D; Regmi R; Bowen SR; Bloch C; Wong T
    Transl Lung Cancer Res; 2018 Apr; 7(2):171-179. PubMed ID: 29876316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative analysis of dose-averaged linear energy transfer (LET
    Rana S; Traneus E; Jackson M; Tran L; Rosenfeld AB
    Med Phys; 2022 May; 49(5):3444-3456. PubMed ID: 35194809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvements in pencil beam scanning proton therapy dose calculation accuracy in brain tumor cases with a commercial Monte Carlo algorithm.
    Widesott L; Lorentini S; Fracchiolla F; Farace P; Schwarz M
    Phys Med Biol; 2018 Jul; 63(14):145016. PubMed ID: 29726402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose calculation differences between Monte Carlo and pencil beam depend on the tumor locations and volumes for lung stereotactic body radiation therapy.
    Zhuang T; Djemil T; Qi P; Magnelli A; Stephans K; Videtic G; Xia P
    J Appl Clin Med Phys; 2013 Mar; 14(2):4011. PubMed ID: 23470930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigating volumetric repainting to mitigate interplay effect on 4D robustly optimized lung cancer plans in pencil beam scanning proton therapy.
    Rana S; Rosenfeld AB
    J Appl Clin Med Phys; 2021 Mar; 22(3):107-118. PubMed ID: 33599391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental benchmarking of RayStation proton dose calculation algorithms inside and outside the target region in heterogeneous phantom geometries.
    Ruangchan S; Knäusl B; Fuchs H; Georg D; Clausen M
    Phys Med; 2020 Aug; 76():182-193. PubMed ID: 32693355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of errors in spot size and spot position in robustly optimized pencil beam scanning proton-based stereotactic body radiation therapy (SBRT) lung plans.
    Rana S; Rosenfeld AB
    J Appl Clin Med Phys; 2021 Jul; 22(7):147-154. PubMed ID: 34101334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Technical Note: Treatment planning system (TPS) approximations matter - comparing intensity-modulated proton therapy (IMPT) plan quality and robustness between a commercial and an in-house developed TPS for nonsmall cell lung cancer (NSCLC).
    Liu C; Yu NY; Shan J; Bhangoo RS; Daniels TB; Chiang JS; Ding X; Lara P; Patrick CL; Archuleta JP; DeWees T; Hu Y; Schild SE; Bues M; Sio TT; Liu W
    Med Phys; 2019 Nov; 46(11):4755-4762. PubMed ID: 31498885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.